• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过直接磷酸肽/SH2结构域结合定义磷脂酰肌醇3激酶p85 SH2结构域的特异性

Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.

作者信息

Piccione E, Case R D, Domchek S M, Hu P, Chaudhuri M, Backer J M, Schlessinger J, Shoelson S E

机构信息

Joslin Diabetes Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215.

出版信息

Biochemistry. 1993 Apr 6;32(13):3197-202. doi: 10.1021/bi00064a001.

DOI:10.1021/bi00064a001
PMID:8384875
Abstract

We have developed a competition binding assay to quantify relative affinities of isolated Src-homology 2 (SH2) domains for phosphopeptide sequences. Eleven synthetic 11-12-amino acid phosphopeptides containing YMXM or YVXM recognition motifs bound to a PI 3-kinase p85 SH2 domain with highest affinities, including sequences surrounding phosphorylated tyrosines of the PDGF, CSF-1/c-Fms, and kit-encoded receptors, IRS-1, and polyoma middle T antigens; matched, unphosphorylated sequences did not bind. A scrambled YMXM phosphopeptide or sequences corresponding to the GAP or PLC-gamma SH2 domain binding motifs of the PDGF, FGF, and EGF receptors bound to the p85 SH2 domain with 30-100-fold reduced affinity, indicating that this affinity range confers specificity. Binding specificity was appropriately reversed with an SH2 domain from PLC-gamma: a phosphopeptide corresponding to the site surrounding PDGF receptor Tyr1021 binds with approximately 40-fold higher affinity than a YMXM-phosphopeptide. We conclude that essential features of specific phosphoprotein/SH2 domain interactions can be reconstituted using truncated versions of both the phosphoprotein (a phosphopeptide) and cognate SH2 domain-containing protein (the SH2 domain). SH2 domain binding specificity results from differences in affinity conferred by the linear sequence surrounding phosphotyrosine.

摘要

我们开发了一种竞争性结合检测方法,用于定量分离的Src同源2(SH2)结构域对磷酸肽序列的相对亲和力。11种含有YMXM或YVXM识别基序的合成11 - 12氨基酸磷酸肽与PI 3激酶p85 SH2结构域结合的亲和力最高,包括血小板衍生生长因子(PDGF)、集落刺激因子-1/c-Fms和kit编码受体、胰岛素受体底物-1(IRS-1)以及多瘤病毒中T抗原磷酸化酪氨酸周围的序列;匹配的未磷酸化序列不结合。一种打乱顺序的YMXM磷酸肽或与PDGF、成纤维细胞生长因子(FGF)和表皮生长因子(EGF)受体的GAP或PLC-γ SH2结构域结合基序相对应的序列与p85 SH2结构域结合的亲和力降低了30 - 100倍,表明这种亲和力范围赋予了特异性。用PLC-γ的SH2结构域可适当逆转结合特异性:与PDGF受体Tyr1021周围位点相对应的磷酸肽结合亲和力比YMXM磷酸肽高约40倍。我们得出结论,特定磷酸蛋白/SH2结构域相互作用的基本特征可以通过使用磷酸蛋白(磷酸肽)和含同源SH2结构域蛋白(SH2结构域)的截短版本来重建。SH2结构域的结合特异性源于磷酸酪氨酸周围线性序列赋予的亲和力差异。

相似文献

1
Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.通过直接磷酸肽/SH2结构域结合定义磷脂酰肌醇3激酶p85 SH2结构域的特异性
Biochemistry. 1993 Apr 6;32(13):3197-202. doi: 10.1021/bi00064a001.
2
Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.一种不可水解的膦肽对SH2结构域/磷蛋白结合的抑制作用。
Biochemistry. 1992 Oct 20;31(41):9865-70. doi: 10.1021/bi00156a002.
3
Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.磷脂酰肌醇3激酶p85α调节亚基C端SH2结构域的溶液结构
J Mol Biol. 1998 Feb 20;276(2):461-78. doi: 10.1006/jmbi.1997.1562.
4
Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation.特定磷酸肽结合调节与酶激活相关的PI 3激酶SH2结构域的构象变化。
EMBO J. 1993 Feb;12(2):795-802. doi: 10.1002/j.1460-2075.1993.tb05714.x.
5
SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.SH2结构域对酪氨酸磷酸化肽段具有高亲和力结合,但也表现出快速解离和交换。
Mol Cell Biol. 1993 Mar;13(3):1449-55. doi: 10.1128/mcb.13.3.1449-1455.1993.
6
IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.胰岛素受体底物-1(IRS-1)通过与p85的src同源结构域2结合来激活磷脂酰肌醇3'-激酶。
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10350-4. doi: 10.1073/pnas.89.21.10350.
7
Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.Src SH2结构域与磷酸化肽段的结合由SH2结构域和磷酸化肽段中的残基共同决定。
Mol Cell Biol. 1993 Dec;13(12):7278-87. doi: 10.1128/mcb.13.12.7278-7287.1993.
8
In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.磷脂酰肌醇3激酶调节亚基(p85)与人胰岛素受体的体外结合
Int J Pept Protein Res. 1995 Nov;46(5):346-53. doi: 10.1111/j.1399-3011.1995.tb01067.x.
9
SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.SH-PTP2/Syp的SH2结构域结合特异性是由其与血小板衍生生长因子β受体、表皮生长因子受体以及胰岛素受体底物-1衍生的磷酸肽的直接相互作用所决定的。
J Biol Chem. 1994 Apr 8;269(14):10467-74.
10
Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.酪氨酸磷酸化肽与SH2结构域结合的测量:重新评估。
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3199-203. doi: 10.1073/pnas.92.8.3199.

引用本文的文献

1
Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet.磷酸肽与酪氨酸磷酸酶SHP2的N-SH2结构域结合与其中心β-折叠的解开相关。
Comput Struct Biotechnol J. 2024 Mar 2;23:1169-1180. doi: 10.1016/j.csbj.2024.02.023. eCollection 2024 Dec.
2
Dynamic molecular architecture and substrate recruitment of cullin3-RING E3 ligase CRL3.动态分子结构与底物募集的 Cullin3-RING E3 连接酶 CRL3
Nat Struct Mol Biol. 2024 Feb;31(2):336-350. doi: 10.1038/s41594-023-01182-6. Epub 2024 Feb 8.
3
Class I PI3K Biology.
I 类 PI3K 生物学。
Curr Top Microbiol Immunol. 2022;436:3-49. doi: 10.1007/978-3-031-06566-8_1.
4
The loops of the N-SH2 binding cleft do not serve as allosteric switch in SHP2 activation.N-SH2 结合裂隙的环不充当 SHP2 激活的别构开关。
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17). doi: 10.1073/pnas.2025107118.
5
PI3K Driver Mutations: A Biophysical Membrane-Centric Perspective.PI3K 驱动突变:一种基于生物物理膜的视角。
Cancer Res. 2021 Jan 15;81(2):237-247. doi: 10.1158/0008-5472.CAN-20-0911. Epub 2020 Oct 12.
6
Control of T lymphocyte fate decisions by PI3K signaling.PI3K 信号对 T 淋巴细胞命运决定的控制。
F1000Res. 2020 Sep 25;9. doi: 10.12688/f1000research.26928.1. eCollection 2020.
7
Specificity and regulation of phosphotyrosine signaling through SH2 domains.通过SH2结构域的磷酸酪氨酸信号传导的特异性与调控
J Struct Biol X. 2020 May 27;4:100026. doi: 10.1016/j.yjsbx.2020.100026. eCollection 2020.
8
The kinetics of folding of the NSH2 domain from p85.p85 亚基 NSH2 结构域的折叠动力学
Sci Rep. 2019 Mar 11;9(1):4058. doi: 10.1038/s41598-019-40480-2.
9
HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3.肿瘤中 HER2 的扩增会激活 PI3K/Akt 信号通路,而不依赖于 HER3。
Cancer Res. 2018 Jul 1;78(13):3645-3658. doi: 10.1158/0008-5472.CAN-18-0430. Epub 2018 May 14.
10
Identification of a new interaction mode between the Src homology 2 domain of C-terminal Src kinase (Csk) and Csk-binding protein/phosphoprotein associated with glycosphingolipid microdomains.鉴定 C 端Src 激酶(Csk)Src 同源 2 结构域与与神经酰胺糖脂微域结合的 Csk 结合蛋白/磷酸化蛋白之间的新相互作用模式。
J Biol Chem. 2013 May 24;288(21):15240-54. doi: 10.1074/jbc.M112.439075. Epub 2013 Apr 2.